Johns Hopkins Medicine’s newly established Institute forFundamental Biomedical Research (IFBR) located at The Johns HopkinsAll Children’s Hospital in St. Petersburg, FL site has openings forfaculty at the Assistant Professor or Associate Professorlevel.We are interested in candidates whose proposed research hasrelevance to the control of metabolism and related to diseasestates with broad relevance to children’s health. Additionally,preferred research areas include, but are not limited to genomics,epigenomics, nuclear receptor research, lipid signaling,bioinformatics, transcriptional and system level analyses of cellsand tissues involved in whole body metabolism and/or diseaseprocesses. Candidates whose research offers translational potentialin obesity, diabetes, endocrine, inflammatory or degenerativediseases are particularly encouraged to apply.The Faculty opportunities require a PhD or MD/PhD in BiologicalScience or related field with outstanding training and experiencein research pertaining to one of the focus areas noted above.Candidates are expected to establish rigorous and competitive basicresearch programs addressing unmet clinical needs, and to securesupport from diverse funding sources. Applicants are also expectedto collaborate with existing members of IFBR and other JohnsHopkins faculty located both in Florida and Baltimore. Successfulcandidates are expected to have an impressive publication recordand exceptional research accomplishments consistent with theiracademic level. Proven ability to secure external funding would bea plus.Interested candidates should submit a CV, cover letter, selectionof representative publications, research statement and 3 referees.Please contact Laszlo Nagy with questions at [email protected] or toprovide additional documents.Johns Hopkins University is committed to active recruitment of adiverse faculty and student body. The University is an AffirmativeAction/Equal Opportunity Employer of women, minorities, protectedveterans and individuals with disabilities and encouragesapplications from these and other protected group members.Consistent with the University’s goals of achieving excellence inall areas, we will assess the comprehensive qualifications of eachapplicant.PhD or MD/PhD in Biological Sciences or related fieldStrong publication historyPlease apply via Interfolio and include your CV, cover letter,selected publications, research statement and 3 refereesThe Johns Hopkins University is committed to equal opportunity forits faculty, staff, and students. To that end, the university doesnot discriminate on the basis of sex, gender, marital status,pregnancy, race, color, ethnicity, national origin, age,disability, religion, sexual orientation, gender identity orexpression, veteran status or other legally protectedcharacteristic. The university is committed to providing qualifiedindividuals access to all academic and employment programs,benefits and activities on the basis of demonstrated ability,performance and merit without regard to personal factors that areirrelevant to the program involved.The successful candidate(s) for this position will be subject to apre-employment background check.If you are interested in applying for employment with The JohnsHopkins University and require special assistance or accommodationduring any part of the pre-employment process, please contact theHR Business Services Office at [email protected] For TTYusers, call via Maryland Relay or dial 711.The following additional provisions may apply depending on whichcampus you will work. Your recruiter will adviseaccordingly.During the Influenza (“the flu”) season, as a condition ofemployment, The Johns Hopkins Institutions require all employeeswho provide ongoing services to patients or work in patient care orclinical care areas to have an annual influenza vaccination orpossess an approved medical or religious exception. Failure to meetthis requirement may result in termination of employment.The pre-employment physical for positions in clinical areas,laboratories, working with research subjects, or involvingcommunity contact requires documentation of immune status againstRubella (German measles), Rubeola (Measles), Mumps, Varicella(chickenpox), Hepatitis B and documentation of having received theTdap (Tetanus, diphtheria, pertussis) vaccination. This may includedocumentation of having two (2) MMR vaccines; two (2) Varicellavaccines; or antibody status to these diseases from laboratorytesting. Blood tests for immunities to these diseases areordinarily included in the pre-employment physical exam except forthose employees who provide results of blood tests or immunizationdocumentation from their own health care providers. Anyvaccinations required for these diseases will be given at no costin our Occupational Health office.Equal Opportunity EmployerNote: Job Postings are updated daily and remain online untilfilled.EEO is the LawLearn more:https://www1.eeoc.gov/employers/upload/eeoc_self_print_poster.pdfImportant legal informationhttp://hrnt.jhu.edu/legal.cfm
To access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week. Would you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletters
BRUSSELS, Mar 2, CMC –The European Sugar Refineries Association (ESRA) says while it is not seeking to abandon sugar imports from the African, Caribbean and Pacific (ACP) countries, the current market situation “simply does not allow us to import from these partners”.ESRA outlined its position in a study presented on January 30 to the European Parliament, a copy of which has been obtained by the Caribbean Media Corporation (CMC).Seeking competitive prices In the study, conducted earlier this year, ESRA said that should the prices for the raw materials from the ACP and Less Developed Countries (LDC) become “competitive” for its members “there is no reason why we would not use these sources of raw materials.“However, the current market situation simply does not allow us to import from these partners. We are not asking for unlimited access to the global sugar supply. We understand that our supplies will always face some limitations due to political sensitivities in the EU sugar sector. “All ESRA is asking for is the chance to compete in the EU sugar sector, through the provision of meaningful access to raw sugar,” it said.On Friday, the ACP and the LDC called for a level playing field for all sugar stakeholders after the study presented to the European Parliament implicated them in the substantial decline in the price and export of the commodity over the past two years.Over-production of subsidy-fueled EU sugarBut the ACP Sugar Group, representing ACP and LDC sugar industries in 18 developing countries, said that the current problems in the EU sugar market were caused by the over-production of subsidy-fueled EU sugar, which has led to record low prices in European markets and to consequent reductions in demand for sugar imported from developing countries.Latest figures published by the European Commission, showed the weighted average EU domestic price had fallen to a new low of Euro 31.4 (One Euro=US$1.29 cents) per kilo, and imports from ACP and LDC countries are currently less than a third of the levels recorded before quotas were abolished.The ACP Sugar Group contend that the EU over-production has also led to EU exports doubling in volume and taking market share in ACP regional markets, displacing ACP and LDC sugar both in the EU and in ACP sugar’s neighboring developing country markets.In the study, ESRA argues that the changed EU market in which it now operates “means that our access to the global supply of raw sugar is even more severely restricted than in the past.“We believe this can be resolved,” it said, noting that it would “like to remind stakeholders what we are not … asking decision-makers to impose any kind of restrictions on domestic sugar production in the EU. “Indeed, we hope for a fully liberalized sector in which we can join our beet processing colleagues in a truly competitive market.Duty-free access crucialESRA said that the only way it can compete in the EU sugar sector “in a manner that is fair to our sector is through the inclusion of duty-free access to raw sugar through EU free trade agreements with raw sugar exporters.“If we fail to gain access to raw sugar, there will be no more discussion, as our sector will cease to exist.To avoid this scenario, EU negotiators must remember that, when it comes to sugar, it is a mistake to approach these talks from a purely defensive point of view.“We are EU stakeholders too, and we need EU negotiators to remember this. We need them to stand with us in these talks, and to fight for the access that can save our historic industry from an almost certain demise,” ESRA said in the study.The ACP Sugar Group said the study suggests a higher cost for imported ACP/LDC sugar mistakenly using data that includes not just the price paid for raw sugar for refining but also the price paid for premium specialty sugars.ACP and LDC sugar producers agree with ESRA’s assessment that the root cause of the decline is overproduction. However, they dispute ESRA’s proposed solutions and they ask the EU not to further erode preferences for ACP and LDC countries by increasing the supply of sugar in an already oversupplied market through additional import quotas, lower MFN (most favored nation) tariffs and/or new free trade agreements (FTAs).The ACP Sugar Group said it also supports ESRA that the EU market has been badly managed by policy-makers.